Study guide

2.7 Drug Utilization Review (DUR) & Submission Clarification Codes

PTCB Billing and Reimbursement Certificate Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

0.1 PTCB Billing & Reimbursement Exam Facts 0.2 Blueprint Breakdown & Study Strategy

2 Chapter 1: Third-Party Programs & Eligibility

1.1 Commercial Insurance & Managed Care Models 1.2 Medicare Pharmacy Coverage: Parts A, B, C, and D 1.3 Medicaid, Dual Eligibles, & Government Safety-Net Programs 1.4 Military, Veterans, & Worker's Compensation Programs 1.5 Patient Assistance Programs, Copay Cards, & 340B Drug Pricing 1.6 Patient Eligibility Verification & Coordination of Benefits (COB) 1.7 Healthcare Reimbursement Systems Across Care Settings

3 Chapter 2: Pharmacy Claims Processing & Adjudication

2.1 NCPDP Telecommunication Standards & Claim Data Elements 2.2 Pharmacy Pricing Structures & Cost Determinations 2.3 Patient Cost-Sharing Calculations: Copays, Coinsurance, & Deductibles 2.4 Dispense as Written (DAW) Codes & Product Selection Logic 2.5 Real-Time Adjudication Workflow & Claim Lifecycle 2.6 NCPDP Reject Codes & Troubleshooting Strategies 2.7 Drug Utilization Review (DUR) & Submission Clarification Codes 2.8 Compound, Specialty, & Partial Fill Adjudication

4 Chapter 3: Prior Authorization & Appeals

3.1 Formulary Management & Utilization Management Controls 3.2 Prior Authorization Criteria & Clinical Documentation Requirements 3.3 Electronic Prior Authorization (ePA) & Submission Portals 3.4 PA Denials, Peer-to-Peer Reviews, & Formal Appeals

5 Chapter 4: Audits & Compliance

4.1 PBM Audit Types, Triggers, & Procedures 4.2 Prescription Documentation, Signature Capture, & Record Retention 4.3 Fraud, Waste, and Abuse (FWA), False Claims, & Regulatory Compliance

6 Chapter 5: Medical Claims Processing & Adjudication

5.1 Medical vs. Pharmacy Benefit Billing & Clinical Pharmacy Services 5.2 Medical Coding Systems (CPT, HCPCS, ICD-10) & CMS-1500 Billing

2.7 Drug Utilization Review (DUR) & Submission Clarification Codes

Key Takeaways Explain This Topic AI

Prospective Drug Utilization Review (ProDUR) screens claims electronically at point of sale for clinical safety hazards, including Drug-Drug Interactions (DD), Therapeutic Duplication (TD), and High Dose (HD).

Resolving an NCPDP DUR alert requires populating the 3-part DUR/PPS segment: Reason for Service (Conflict Code), Professional Service Code (Intervention), and Result of Service Code (Outcome).

Submission Clarification Codes (SCC, Field 420-DK) communicate specific dispensing circumstances to override administrative rejections.

Crucial SCC values include SCC 03 (Vacation Supply), SCC 04 (Lost Prescription), SCC 05 (Therapy Change / Dose Increase), SCC 07 (Medically Necessary — used for urgent/emergency fills), and SCC 20 (340B Claim).

Improper or fraudulent use of SCC overrides to bypass legitimate PBM limits without clinical documentation triggers severe audit clawbacks.

Last updated: August 2026

2.7 Drug Utilization Review (DUR) & Submission Clarification Codes

Prescription claims processing is not merely a financial billing pipeline; it is an active clinical safety checkpoint. Under the Omnibus Budget Reconciliation Act of 1990 ( OBRA '90 ), pharmacies are legally required to maintain Prospective Drug Utilization Review (ProDUR) systems to screen prescription orders for clinical safety issues prior to dispensing.

When a safety issue or unique dispensing circumstance occurs, the pharmacy must communicate clinical interventions and administrative justifications to the payer. This is accomplished using the NCPDP DUR/PPS Segment (Professional Pharmacy Services) and Submission Clarification Codes (SCC) .

1. Prospective DUR (ProDUR) Conflict Categories

During Gate 4 of electronic adjudication, the PBM engine screens the submitted claim against the patient's centralized 12-month prescription history across all participating network pharmacies. If a potential clinical hazard is detected, the engine triggers a ProDUR alert: +-----------------------------------------------------------------------------+

  • | COMMON PRODUR SAFETY CONFLICTS |
  • | |
  • | [DD] DRUG-DRUG INTERACTION -> Co-administration causes adverse harm |
  • | [TD] THERAPEUTIC DUPLICATION -> Two drugs in same therapeutic class |
  • | [HD] HIGH DOSE / OVERDOSAGE -> Dose exceeds FDA maximum safety limit |
  • | [ID] INGREDIENT DUPLICATION -> Same active ingredient in 2 products |
  • | [PA] AGE PRECAUTION -> Inappropriate for pediatric/geriatric |
  • | [ER] EARLY REFILL -> Utilization threshold not met |
  • +-----------------------------------------------------------------------------+

Conflict Code Clinical Definition Real-World Pharmacy Example

DD Drug-Drug Interaction Patient taking warfarin is prescribed ciprofloxacin (which significantly potentiates warfarin's anticoagulant effect, dramatically increasing hemorrhage risk).

TD Therapeutic Duplication Patient is prescribed lisinopril while active claims exist for losartan (concurrent use of two renin-angiotensin system blockers without clinical rationale).

HD High Dose / Overdosage Prescription written for atorvastatin 160 mg daily (FDA maximum approved dose is 80 mg daily).

ID Ingredient Duplication Prescription for Percocet (oxycodone/acetaminophen) billed while patient is actively filling Fioricet (butalbital/acetaminophen/caffeine), risking acute acetaminophen hepatotoxicity.

PA / SX Age Precaution / Gender Alert Prescription for diazepam in an 82-year-old patient (Beers Criteria warning for severe fall/fracture risk in elderly).

DA Drug-Allergy Conflict Patient with a documented anaphylactic penicillin allergy is prescribed amoxicillin.

2. The 3-Part NCPDP DUR/PPS Segment Structure

When a ProDUR alert generates NCPDP Reject 88 , the pharmacist must evaluate the clinical risk. If the pharmacist consults the prescriber or patient and determines that the medication can be safely dispensed, the claim is retransmitted with the NCPDP DUR/PPS Segment (Segment 11).

The DUR/PPS segment requires a mandatory 3-part code combination that describes the conflict, the action taken, and the clinical outcome: +-----------------------------------------------------------------------------+

  • | THE 3-PART DUR/PPS CODE ARCHITECTURE |
  • | |
  • | [PART 1: REASON FOR SERVICE] -> Identifies the Conflict (e.g., DD, TD) |
  • | + |
  • | [PART 2: PROFESSIONAL SERVICE]-> Identifies the Intervention (e.g., M0, P0)|
  • | + |
  • | [PART 3: RESULT OF SERVICE] -> Identifies the Clinical Outcome (e.g., 1G)|
  • +-----------------------------------------------------------------------------+
  • 1. Reason for Service Code (Conflict Code - Field 439-E4)

Identifies the clinical hazard detected (e.g., DD = Drug-Drug Interaction, TD = Therapeutic Duplication, HD = High Dose, ER = Early Refill).

2. Professional Service Code (Intervention Code - Field 440-E5)

Identifies the action taken by the pharmacy staff to investigate and resolve the hazard:

M0 = Prescriber Consulted (pharmacist contacted prescriber directly).

P0 = Patient Consulted (pharmacist interviewed patient regarding adherence/symptoms).

R0 = Pharmacist Consulted Other Source (reviewed clinical compendia, lab values, or medical records).

AS = Patient Assessment (performed clinical assessment or vital check).

TH = Therapeutic Product Interchange (substituted formulary alternative with approval).

3. Result of Service Code (Outcome Code - Field 441-E6)

Identifies the final resolution of the clinical intervention:

1B = Filled Prescription as Written (Directions clarified/confirmed safe).

1C = Filled with Different Dose (Prescriber adjusted strength/dose).

1D = Filled with Different Directions (SIG clarified or altered by prescriber).

1E = Filled with Different Drug (Alternative agent selected).

1F = Filled with Different Quantity.

1G = Filled with Prescriber Approval (Prescriber verified benefit outweighs risk).

2A = Prescription Not Filled (Medication canceled due to safety hazard).

2B = Prescription Not Filled - Directions Followed.

Standard DUR Override Combinations:

  • Drug Interaction Approved by MD: Reason: DD | Professional: M0 | Result: 1G
  • Therapeutic Duplication Confirmed (Discontinuing Old Med): Reason: TD | Professional: M0 | Result: 1B
  • Dose Clarified & Reduced by Prescriber: Reason: HD | Professional: M0 | Result: 1C

3. Submission Clarification Codes (SCC - Field 420-DK)

While DUR codes resolve clinical safety alerts, Submission Clarification Codes (SCC) (Field 420-DK) are 2-digit numeric codes entered by the pharmacy technician or billing coordinator to clarify non-standard administrative dispensing situations. +-----------------------------------------------------------------------------+

  • | HIGH-YIELD SUBMISSION CLARIFICATION CODES |
  • | |
  • | [SCC 03] VACATION SUPPLY -> Member traveling outside service area |
  • | [SCC 04] LOST PRESCRIPTION -> Accidental loss, spill, or theft |
  • | [SCC 05] THERAPY CHANGE / DOSE -> Physician increased daily dosage |
  • | [SCC 07] MEDICALLY NECESSARY -> Urgent / emergency dispensing fills |
  • | [SCC 08] COMPOUND APPROVED INGR. -> Process compound for approved ingred. |
  • | [SCC 20] 340B DRUG CLAIM -> Covered entity safety-net dispensing |
  • +-----------------------------------------------------------------------------+

SCC Code Title / Purpose Operational Scenario & Workflow Requirements

03 Vacation Supply The patient is traveling outside the plan's pharmacy network or overseas and requires an advance refill before the standard refill threshold. PBMs typically permit 1 to 2 vacation overrides per plan year. Technician documents travel dates in PMS notes.

04 Lost Prescription The patient's medication was accidentally lost, destroyed (e.g., dropped down sink, left on airplane), or stolen. Most commercial and Medicare plans allow 1 replacement override per year per medication. Stolen controlled substances require a formal police report for audit compliance.

05 Therapy Change / Dosage Increase The prescriber increased the patient's daily dose (e.g., from 1 tablet daily to 2 tablets daily). Because the patient consumed the previous fill at the higher rate, the supply ran out early. Submitting SCC 05 overrides Reject 79 and establishes the new dosing baseline.

07 Medically Necessary Declares the dispensing medically necessary. Several Medicaid programs (e.g., NY Medicaid/eMedNY) direct pharmacies to use SCC 07 when dispensing an urgent or 72-hour emergency supply of a life-sustaining maintenance drug that is blocked by a Prior Authorization (Reject 75) on a weekend or holiday.

08 Process Compound for Approved Ingredients Instructs the adjudication engine to price a multi-ingredient compound using only the covered, plan-approved ingredients.

20 340B Drug Claim Identifies that the dispensed drug was purchased under the federal 340B Drug Pricing Program, preventing duplicate Medicaid statutory rebates under federal law.